semaglutide news october 16 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow

Big News: Medicare & Medicaid Could Soon Cover GLP-1s for Weight Management, A new 5-year federal experiment may finally open access to GLP-1 medications—like Ozempic, Wegovy, Mounjaro, and

22.03

★★★★☆4.8 (126)

Trump says price of Ozempic will be lowered

24.46

★★★★★4.9 (98)

Semaglutide effectively treats liver disease in two thirds of patients, research finds

25.57

★★★★★5.0 (157)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

22.22

★★★★★4.7 (84)

Sinopep has obtained FDA First Adequate Letter for Semaglutide

23.65

★★★★★4.9 (203)

Turns out all those studies that estimated you could make a month's worth of semaglutide for $5 or less were probably correct

22.80

★★★★★5.0 (176)

The FDA recently approved the Wegovy pill—the first oral #GLP-1 receptor agonist indicated for obesity. How does oral #semaglutide stack up against the injection in terms of cost, dosing, and adverse effects?

29.34

★★★★★4.8 (132)